NAVIDEA BIOPHARMACEUTICALS, INC. NAVB Income Statement

Navidea biopharmaceuticals, inc. (NAVB)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Revenue from contract with customer
39	38	71	88	336	338	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Tc99m tilmanocept sales revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	39	-6,701	-3,766	-1,807	19	7,852	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Lymphoseek sales revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	271	0	0	-	0	-	-	-	-	-	-	-	0
Tc99m tilmanocept license revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	1,795	2,045	1,300	1,304	1,133	883	633	383	300	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Grant and other revenue
733	631	598	576	609	846	1,148	1,163	1,396	1,701	2,338	2,625	3,030	3,136	2,653	2,619	2,356	1,860	2,169	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Lymphoseek milestone revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Grant and other revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	324	127	0	-	0	0	-	-	-	-	0	-	-
License and grant revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Revenues, Total
772	657	657	652	934	1,169	1,445	1,437	1,506	1,810	2,447	4,047	4,603	4,971	-2,002	152	1,853	3,013	6,933	5,203	3,410	2,054	4,611	2,761	1,882	1,130	602	202	66	78	327	333	0	-	0	0	-	0	0
Cost of revenue
1	6	29	67	102	96	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of goods sold
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of goods sold
-	-	-	-	-	-	-	-	-	-	-	-	-	62	-1,230	-776	-444	3	-29	320	258	2	1,423	691	526	332	180	0	0	-	0	-	-	-	-	-	-	-	0
Gross profit
771	651	628	585	832	1,072	1,367	1,398	1,502	1,806	2,390	3,987	4,542	4,909	-771	928	2,297	3,010	6,962	4,883	3,152	2,051	3,187	2,070	1,356	797	414	149	0	-	0	0	-	-	-	-	-	-	0
Operating expenses:
Research and development
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, general and administrative
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research and development
5,596	5,338	4,467	3,891	3,963	4,221	5,115	4,764	4,807	4,513	4,892	4,937	5,771	7,138	5,393	8,375	8,653	10,562	0	0	0	-	-	0	0	-	18,638	18,487	16,586	16,890	19,541	17,272	16,662	15,154	10,640	8,520	0	0	0
Selling, general and administrative
6,374	6,275	6,553	7,722	7,650	7,698	8,417	7,463	9,923	11,169	11,094	11,171	8,309	7,920	3,235	5,366	8,027	10,888	0	0	0	-	-	-	-	-	14,195	13,166	11,967	11,177	10,535	10,464	9,220	9,547	8,786	6,834	0	0	0
Selling, general and administrative
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
11,971	11,613	11,020	11,613	11,613	11,920	13,533	12,228	14,731	15,683	15,986	16,108	14,080	15,058	8,628	13,741	16,680	21,450	22,347	21,306	24,980	24,642	39,398	42,842	41,369	39,236	32,833	31,653	28,553	28,068	30,077	27,736	25,883	24,702	19,427	15,354	0	0	0
Loss from operations
-11,200	-10,962	-10,392	-11,028	-10,781	-10,847	-12,165	-10,830	-13,228	-13,877	-13,596	-12,121	-9,538	-10,148	-9,399	-12,813	-14,383	-18,440	-15,384	-16,423	-21,828	-22,591	-36,210	-40,772	-40,013	-38,438	-32,411	-31,556	-28,487	-27,989	-30,005	-27,409	-25,609	-24,104	-18,680	-13,135	0	0	0
Other income (expense):
Interest income, net
-	-	-	-	-	-	-	-	176	168	142	66	18	-4	3,418	1,270	-302	-1,269	-5,290	-4,059	-3,393	-3,363	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest (expense) income, net
13	25	-4	-40	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11	10	16	25	34	37	31	25	16	10	0	0	0
Interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,040	1,379	1,235	1,166	940	625	305	13	4	272	0	0	0
Equity in loss of R-NAV, LLC
-	-	-	-	-	-	-	-	-	-	-	-	-	-15	-25	-51	-55	-305	-556	-792	-786	-523	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Loss on disposal of investment in R-NAV, LLC
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of financial instruments
-	-	-	-	-	-	-	-	-	153	1,255	416	1,873	2,858	2,844	2,106	-1,216	-614	-2,935	-1,768	-7	-1,342	155	188	280	-112	-93	0	0	-	0	-	-	-	-	-	-	-	-
Change in fair value of financial instruments
-	-	-	-	-	-	-	-	-	153	0	0	0	-	0	0	-	-	-	-	-	-1,342	0	0	0	-	-93	0	0	-	0	-	-	-	-	-	-	-	-
Loss on extinguishment of debt
-	-	-	-	-	-5,291	-7,153	-7,153	-7,153	-4,201	-1,314	-1,314	-1,314	0	-2,440	0	0	-	-	0	-	-2,610	-2,610	-2,610	-3,982	-1,372	-1,372	0	0	-	0	-	-	-	-	-	-	-	0
Change in derivative liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-1,044	-1,206	0	0	0
Other, net
-6	-7	-6	-1	4	1	13	3	-16	-33	-23	-28	-12	-27	-49	-32	-37	26	57	106	106	72	41	-45	-48	-16	-16	14	-19	-58	-60	-58	-17	-3	-1	-3	0	0	0
Total other income (expense), net
6	17	-1,019	-1,054	-1,073	-5,321	-7,135	-7,041	-6,980	-3,912	60	-860	523	2,770	6,148	3,252	-4,052	-4,603	-11,166	-8,954	-4,081	-7,767	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss before income taxes
-11,193	-10,944	-11,411	-12,083	-11,855	-16,168	-19,301	-17,871	-20,208	-17,789	-13,536	-12,981	-9,014	-7,377	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss before income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-25,047	-19,714	0	0	0	-
Provision for income taxes
-	0	76	66	0	-	0	0	-	-4,062	-3,861	-3,085	-1,454	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-7,880	0	0	0	-	-
Net loss from continuing operations
-11,193	-10,945	-11,337	-12,085	-11,846	-16,158	-19,165	-16,883	-17,600	-13,727	-9,675	-9,895	-7,560	-7,377	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Discontinued operations, net of tax effect:
Loss from discontinued operations, net of tax effect
-	-2	-4	-4	0	-	-	0	-	-490	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,329	3,042	3,262	0	0	0
Gain on sale of discontinued operations, net of tax effect
-	-	-	-	-	-	-	0	-	89,163	86,894	86,748	88,701	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Net loss
-11,192	-10,948	-11,336	-12,084	-11,805	-16,114	-17,012	-14,579	-17,373	74,945	0	0	0	-	0	0	-	-27,563	-31,952	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income (loss) attributable to noncontrolling interest
-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	0	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net income (loss) attributable to common stockholders
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	0	0	-	-	-	-	-	-29,530	-599	3,046	5,612	10,839	-52,062	0	0	0
Deemed dividend on beneficial conversion feature of MT Preferred Stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	46	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deemed dividend on beneficial conversion feature of MT Preferred Stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total other expense, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-3,770	-2,418	-1,022	-1,167	-954	-912	-473	-943	-1,034	-43,188	0	0	0
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-17,167	-12,311	-55,324	0	0	0
Preferred stock dividends
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	43	100	100	100	100	100	8,171	0	0	0
Net loss attributable to common stockholders
-11,192	-10,948	-11,336	-12,084	-11,805	-16,113	-17,011	-14,579	-17,373	74,946	0	0	0	-	-	-	-23,957	-27,608	-31,963	-30,791	-31,323	-35,726	-42,613	-47,020	-47,098	-42,699	-36,150	-33,968	-29,527	-29,200	-29,630	-699	2,946	5,512	10,739	-60,234	0	0	0
Continuing operations (in dollars per share)
-	-	-0.17	-0.24	-	-	-0.46	-0.30	-0.83	-0.03	-0.01	-0.02	-0.02	-0.01	-0.01	-0.01	-0.02	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Discontinued operations (in dollars per share)
-	-	-	-	-	-	-	-	-	0.01	0.00	-0.01	0.55	-0.02	0.01	-0.03	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Attributable to common stockholders (in dollars per share)
-	-	-	-	-	-	-	-	-0.83	-0.02	-0.01	-0.03	0.53	-0.03	0.00	-0.04	-0.02	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average shares outstanding (in shares)
-	-	-	-	-	-	-	-	8,113	162,076	162,006	161,910	160,376	155,517	155,481	155,382	155,308	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Continuing operations (in dollars per share)
-	-	-	-	-	-	-	-	-	-0.03	-0.01	-0.02	-0.02	-0.01	-0.01	-0.01	-0.02	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Discontinued operations (in dollars per share)
-	-	-	-	-	-	-	-	-	0.00	0.00	-0.01	0.54	-0.02	0.01	-0.03	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Attributable to common stockholders (in dollars per share)
-	-	-	-	-	-	-	-	-	-0.03	-0.01	-0.03	0.52	-0.03	0.00	-0.04	-0.02	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average shares outstanding (diluted) (in shares)
-	-	-	-	-	-	-	-	-	175,276	162,006	161,910	164,871	155,517	155,481	155,382	155,308	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss per common share (basic and diluted):
Continuing operations (in dollars per share)
-0.13	-	-	-	-0.24	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.08	0.00	-0.03	-0.06	-0.05	-0.64
Discontinued operations (in dollars per share)
-	-	-	-	-	-	-	0.01	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.21	0.01	0.01	0.02	0.00
Attributable to common stockholders (in dollars per share)
-0.13	-0.11	-0.17	-0.24	-0.24	-	-0.46	-0.29	-	-	-	-	-	-	-	-	-	-	-0.05	-0.06	-0.05	-0.04	-0.05	-0.07	-0.08	-0.11	-0.09	-0.09	-0.06	-0.07	-0.09	-0.06	-0.07	-0.08	0.21	-0.02	-0.05	-0.03	-0.64
Weighted average shares outstanding (in shares)
20,203	18,414	18,044	11,096	10,017	-	8,342	8,135	-	-	-	-	-	-	-	-	-	-	150,186	150,107	149,794	150,020	150,169	150,019	144,783	134,094	121,117	118,260	113,763	105,167	102,332	94,664	94,074	-	93,070	89,660	-	-	-
Basic and diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	85,416	80,605	80,260
Net income (loss)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Preferred stock dividends
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Royalty [Member]
Revenue from contract with customer
28	16	19	16	17	15	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
License [Member]
Revenue from contract with customer
-	-	-	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-